Table 2.

The registries have a shared objective of understanding the interplay between COVID-19 and skin conditions

Registry	Objective
AAD/ILDS	To capture observations from health care providers worldwide in order to understand dermatologic manifestations of COVID-19 and form hypotheses about the virus
SECURE-Alopecia	To capture observations from health care providers worldwide in order to understand the impact of alopecias and their therapies on COVID-19 and whether the virus induces alopecia
SECURE-AD	To uncover the underlying determinants of the outcomes of COVID-19 in patients with AD who are treated with systemic immunomodulating medication, and—through the patient survey—to better understand how COVID-19 affects AD patients and improve their care
PsoProtect	To characterize the course of COVID-19 in people with psoriasis and the factors associated with adverse outcomes through a physician-reported registry
PsoProtectMe	To characterize the behaviors and experiences of people with psoriasis during the COVID-19 pandemic, regardless of COVID-19 infection, through a patient-reported registry
SECURE-Psoriasis	To collect cases of psoriasis patients diagnosed with COVID-19 and examine the disease course and clinical outcomes in psoriasis patients, and to evaluate patient factors that may lead to better or worse COVID-19 outcomes
HS COVID	To identify predictors of COVID-19 outcomes and improve the care of patients with HS
PeDRA	To collect cases of acral pernio-like changes identified in pediatric patients through a registry for health care providers in order to capture and document this newly observed phenomenon and determine its relationship to COVID-19 by symptoms, exposure, and formal testing